Prognostic value of posttreatment HPV-specific antibodies in patients with oropharyngeal tumors

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023736%3A_____%2F19%3A00012662" target="_blank" >RIV/00023736:_____/19:00012662 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11110/19:10395611 RIV/00216208:11310/19:10395611 RIV/61989592:15310/19:73599119 RIV/00064203:_____/19:10395611
Result on the web
<a href="https://doi.org/10.1002/jso.25473" target="_blank" >https://doi.org/10.1002/jso.25473</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1002/jso.25473" target="_blank" >10.1002/jso.25473</a>

Result language
angličtina
Original language name
Prognostic value of posttreatment HPV-specific antibodies in patients with oropharyngeal tumors
Original language description
This prospective study with follow-up focused on the persistence and prognostic value of antibodies specific for HR HPV-derived VLPs and HPV16 E6/E7 oncoproteins in patients with oropharyngeal cancers. In this study, we analyzed sera of 93 patients taken a year after the end of treatment and sera from 58 of these patients taken up to 14 years after treatment.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30205 - Hematology

Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year
2019
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)